John Matsoukas | Chemistry | Excellence in Innovation Award

Published on by Book of Award

Prof. John Matsoukas | Chemistry | Excellence in Innovation Award

University of Patras | Greece

Professor John Matsoukas is a distinguished scholar in the field of chemistry and drug discovery, with over four decades of academic and research contributions spanning peptide chemistry, medicinal chemistry, and rational drug design. He has served as Professor of Chemistry at the University of Patras since 1995 and has held multiple visiting and adjunct appointments internationally, reflecting his global academic influence. His pioneering work in the design of non-peptide mimetics for peptide hormones and immune-related targets has significantly advanced research in hypertension, cancer, multiple sclerosis, and antiviral therapeutics. A prolific author, he has published 189 peer-reviewed papers, 50 book chapters, and numerous conference proceedings, bringing his total scholarly outputs to more than 600. His research has been widely recognized, accumulating over 5,500 citations and an h-index of 42, underscoring both productivity and impact within the scientific community. In addition, his innovative contributions are reflected in multiple patents, editorial roles, and his leadership in founding the Graduate Program in Medicinal Chemistry: Drug Discovery and Design, the first Euromaster-awarded program in Greece. Beyond academia, he has also established spin-offs and startups, securing over €15 million in grants, and continues to shape international biomedical networks, cementing his legacy as a leading figure in drug discovery and medicinal chemistry.

Profile : Scopus | Orcid

Featured Publications

"Docking Simulations of G-Protein Coupled Receptors Uncover Crossover Binding Patterns of Diverse Ligands to Angiotensin, Alpha-Adrenergic and Opioid Receptors: Implications for Cardiovascular Disease and Addiction"

"Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors"

"Semi-Supervised Learning for Predicting Multiple Sclerosis"

"Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses"

"A methamphetamine vaccine using short monoamine and diamine peptide linkers and poly-mannose"

"Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019"

"Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis"

"Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood–Brain Barrier"

Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Monash University | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Masroor Badshah’s academic foundation is marked by a rigorous pursuit of medicine and anatomical sciences. Beginning with his degree in Medicine and Surgery, he developed an early research interest in the clinical relevance of anatomy, completing projects on skin diseases and vascular variations. His postgraduate studies at the University of Dundee expanded his expertise into human anatomy, where he defended a dissertation on carotid artery variations. This path led him to Monash University, where he earned his doctorate in medicine, focusing on oxytocin signaling in regulating the myogenic tone of the prostate and bladder. These early endeavors established a solid base for his later contributions to pharmacology and biomedical sciences.

Professional Endeavors

Dr. Badshah’s professional journey spans multiple countries, reflecting both versatility and international recognition. He began his teaching career as a lecturer and assistant professor in human anatomy at medical institutions in Pakistan before moving to Scotland and later Australia. His teaching associate roles at Monash University and research assistantship at the Monash Institute of Pharmaceutical Sciences allowed him to mentor students, design innovative teaching methodologies, and participate in collaborative research. His clinical internships in medicine and surgery also provided him with practical exposure that enriched his academic and research perspectives.

Contributions and Research Focus

At the core of Dr. Badshah’s career lies his dedication to advancing knowledge in pharmacology, toxicology, and pharmaceutical sciences. His doctoral work investigated the pharmacological role of oxytocin receptor antagonists in bladder and prostate function, with implications for overactive bladder treatments. His broader research includes studies in human surface anatomy, craniofacial asymmetry, morphometry of skeletal structures, and the clinical relevance of anatomical variations. By combining anatomical precision with pharmacological inquiry, he bridges the gap between foundational science and therapeutic application.

Accolades and Recognition

Throughout his career, Dr. Badshah has been honored with prestigious awards and scholarships, including the Monash Graduate Scholarship, Faculty International Tuition Scholarship, and the University of Dundee Tuition Scholarship. His academic excellence is reflected in multiple publications in peer-reviewed journals such as Biomedicines, Clinical Anatomy, and the Italian Journal of Anatomy and Embryology. He has also been a frequent presenter at international conferences, where his research findings on oxytocin signaling and anatomical morphometry have received recognition from the scientific community.

Impact and Influence

Dr. Badshah’s influence extends beyond research publications to shaping the next generation of medical and pharmaceutical scientists. His teaching philosophy emphasizes critical thinking, active participation, and evidence-based learning. By integrating innovative methodologies and fostering a collaborative learning environment, he has left a lasting impression on his students across different institutions. His work in surface anatomy and pharmacological sciences contributes to both clinical education and translational research, making his influence both academic and practical.

Legacy and Future Contributions

As a researcher with interdisciplinary expertise, Dr. Badshah’s legacy lies in his ability to merge anatomy with pharmacology for improved clinical outcomes. His ongoing research into bladder and prostate physiology offers potential breakthroughs in addressing urological disorders. Looking ahead, he aims to expand his collaborations globally, secure independent research leadership, and explore translational aspects of his work that could lead to therapeutic innovations. His legacy will continue to inspire young researchers and contribute to the evolution of biomedical sciences.

Publication

Investigating the Pharmacological Impact of Atosiban, an Oxytocin Receptor Antagonist, on Bladder and Prostate Contractions Within Obese and Non-Obese Rats
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Sarah M. Turpin-Nolan, Khaled A. Elnahriry, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2025

Age-Dependent Effects of Oxytocin and Oxytocin Receptor Antagonists on Bladder Contractions: Implications for the Treatment of Overactive Bladder Syndrome
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2024

The Effects of Age on Prostatic Responses to Oxytocin and the Effects of Antagonists
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2023

Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan
Authors: Sana Hussain, Jamshed Hasnain, Zareen Hussain, Masroor Badshah, Hafeez Siddique, Christina Fiske, April Pettit
Journal: The Open Infectious Diseases Journal
Year: 2018

Morphology of the Human Hard Palate: A Study on Dry Skulls
Authors: Masroor Badshah, Roger Soames, Muhammad Jaffar Khan, Jamshaid Hasnain
Journal: Italian Journal of Anatomy and Embryology
Year: 2018

Conclusion

Dr. Masroor Badshah exemplifies the qualities of a dedicated academic, skilled researcher, and inspiring mentor. His career trajectory reflects a balance of teaching, research, and clinical exposure, with a focus on advancing pharmacology and anatomical sciences. His publications, conference presentations, and mentoring of students have strengthened his academic influence, while his research contributions offer practical applications in medicine. With a strong foundation and a vision for global collaboration, Dr. Badshah’s journey positions him as a leading figure in biomedical and pharmaceutical research, making his recognition as a distinguished researcher both timely and well-deserved.

Adarsh Kumar Shukla | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Adarsh Kumar Shukla | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Dr. Bhimrao Ramji Ambedkar Government Medical College | India

Author Profile

Scopus

Orcid

Google Scholar

 

Early Academic Pursuits

Dr. Adarsh Kumar Shukla laid the foundation of his academic journey with a strong inclination towards life sciences and biological research. Beginning with a degree in Biotechnology, he cultivated a passion for understanding molecular processes and biological systems. His interest in computational and applied biological sciences further deepened during his Master’s studies in Bioinformatics, where he explored the integration of biology with computational technologies. This academic progression culminated in a doctoral degree in Nutrition Biology from the Central University of Haryana, where he investigated nutraceutical compounds, molecular therapeutics, and bioinformatics-based approaches to health and nutrition. His early academic pursuits reflect a strong balance between theoretical learning, laboratory training, and computational applications in life sciences.

Professional Endeavors

Dr. Shukla’s professional career demonstrates a consistent alignment with advanced biomedical research and innovation. He began as a Research Associate and later served as a Scientist in the Department of Paediatric Cardiac Research at Sri Sathya Sai Sanjeevani Research Foundation, contributing to projects on congenital heart diseases and molecular mapping of environmental toxicants. His current role as Scientist-B in the Multidisciplinary Research Unit at Dr. Bhimrao Ramji Ambedkar Government Medical College, Kannauj, highlights his continued commitment to translational biomedical research. Alongside, he has engaged in teaching and faculty development programs, coordinated national scientific conclaves, and participated in capacity-building initiatives in healthcare and nutrition sciences.

Contributions and Research Focus

Dr. Shukla’s research spans a wide spectrum, encompassing structural bioinformatics, human genomics, and nutritional biology. His investigations range from identifying novel bioactive compounds in millets and medicinal plants to computationally mapping toxicants responsible for congenital disorders. His work on psychobiotics and gut-brain regulation has added new insights into neuropsychological health, while his contributions in plant-informatics shed light on the therapeutic potential of natural compounds against viral and bacterial diseases. Additionally, his focus on food-informatics and nutrigenomics has emphasized the role of probiotics, dietary fibers, and bioengineered foods in human health. Through a combination of in-silico and in-vitro studies, his work bridges computational biology with clinical and nutritional sciences.

Accolades and Recognition

Over the course of his career, Dr. Shukla has been recognized for his scientific excellence through awards, patents, and international presentations. He achieved distinction at global scientific forums, securing recognition for his molecular insights into congenital heart disease. His granted Indian patent on crab-apple-based jelly sheets demonstrates his inventive ability to connect traditional resources with modern food biotechnology. Furthermore, his peer-review contributions for high-impact journals and invited roles as a book reviewer underline his standing in the academic community. These achievements illustrate his ability to merge innovation with scholarly rigor.

Impact and Influence

The impact of Dr. Shukla’s research is evident in the interdisciplinary nature of his contributions. His computational models for drug discovery, therapeutic peptides, and congenital heart disease targets provide frameworks for future translational research. His coordination of events such as National Nutrition Month and Women in STEM conclaves reflects his commitment to societal awareness and academic empowerment. By blending computational biology with real-world health challenges, he has influenced research directions in reproductive toxicology, nutraceutical development, and environmental genomics, thereby shaping both scientific knowledge and public health practices.

Legacy and Future Contributions

Dr. Shukla’s academic and professional trajectory reflects the making of a researcher whose work is deeply rooted in societal relevance and interdisciplinary innovation. His legacy lies in advancing computational nutrition biology and medical informatics to address complex health challenges. Looking ahead, his ongoing projects on congenital heart disease, exposome mapping, and nutratherapeutics hold the promise of contributing to precision medicine and sustainable food innovations. His future contributions are likely to expand the integration of bioinformatics with clinical sciences, reinforcing his role as a bridge between molecular insights and healthcare applications.

Present Affiliation

Dr. Adarsh Kumar Shukla is currently serving as Scientist-B in the Multidisciplinary Research Unit at Dr. Bhimrao Ramji Ambedkar Government Medical College, Kannauj, Uttar Pradesh. His role reflects his dedication to advancing multidisciplinary biomedical research with a focus on translational outcomes for healthcare.

Publications

Article: Computational insights into maternal environmental pollutants and folate pathway regulation
Authors: Adarsh Kumar Shukla, Shadab Ahamad, Prachi Kukshal
Journal: Reproductive Toxicology
Year: 2025

Article: Virtual screening of potential orally active anti-bacterial compounds of finger millet
Authors: Raushan Kumar Jha, Adarsh Kumar Shukla, Anita Kumari, Ashwani Kumar
Journal: Vegetos
Year: 2024

Article: Identification of micronutrient deficiency related miRNA and their targets in Triticum aestivum using bioinformatics approach
Authors: Surbhi Panwar, Sunita Pal, Adarsh Kumar Shukla, Ashwani Kumar, Pradeep Kumar Sharma
Journal: Ecological Genetics and Genomics
Year: 2024

Article: Effect of processing techniques on functional, antioxidants, and structural properties of finger millet (Eleusine coracana) flour
Authors: Arzoo, Neeru, Adarsh Kumar Shukla, Surbhi Panwar, Ashwani Kumar
Journal: Food and Humanity
Year: 2024

Article: Nutritional evaluation of probiotics enriched rabadi beverage (PERB) and molecular mapping of digestive enzyme with dietary fibre for exploring the therapeutic potential
Authors: Prakash Yadav, Adarsh Kumar Shukla, Deepika, Neeru, Anita Kumari, Tejpal Dhewa, Ashwani Kumar
Journal: Food and Humanity
Year: 2024

Conclusion

In summary, Dr. Shukla embodies the qualities of a multidisciplinary scientist who blends innovation with social responsibility. His research not only advances scientific understanding but also carries tangible implications for human health and nutrition. With his current role in a government medical research unit and his wide-ranging expertise, he is poised to make enduring contributions to biomedical sciences, food biotechnology, and public health.

Yan Li | Chemistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Yan Li | Chemistry | Best Researcher Award 

Fudan University | China

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Yan Li began his academic journey at the University of Science and Technology of China, where he earned his Bachelor of Science in Chemistry in 2005, under the mentorship of Prof. Youcheng Liu, an esteemed academician of the Chinese Academy of Sciences. He then pursued his Ph.D. at the Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, focusing on molecular modeling and computer-aided drug design under Prof. Renxiao Wang. This rigorous training laid the foundation for his future innovations in computational drug discovery.

💼 Professional Endeavors

Dr. Li's career trajectory is marked by steady progression through prestigious research institutions. From 2010 to 2013, he served as an Assistant Research Fellow at the State Key Laboratory of Bioorganic Chemistry, and was promoted to Associate Professor in 2013. Since 2019, he has held the position of Associate Professor in the Department of Medicinal Chemistry at Fudan University, a leading institution in pharmaceutical sciences. His academic appointments reflect both trust and recognition from the scientific community.

🔬 Contributions and Research Focus

Dr. Li’s research is centered on structure-based drug design, deep learning for molecular generation, and protein-ligand/protein-protein interactions. He develops theoretical models and computational methods to accelerate lead compound discovery and optimization for drug development. His work also delves into identifying interaction patterns in protein-protein interfaces and designing novel small molecules to modulate these interactions — a promising frontier in targeting diseases such as cancer and neurodegeneration.

🏅 Accolades and Recognition

Dr. Li's scientific excellence is evidenced by a robust publication record in high-impact journals like Journal of Medicinal Chemistry, ACS Omega, J. Chem. Inf. Model., and Acta Pharmaceutica Sinica B. He is frequently invited to present at leading conferences, including the Chinese Medicinal Chemistry Symposium, ACS National Meeting, and European QSAR Symposium, highlighting the global relevance and recognition of his research.

🌍 Impact and Influence

Dr. Li’s computational methods and predictive models are widely used in both academic and industrial drug discovery. His work on hydration sites, binding affinity predictions, and molecular simulations has enhanced the precision of virtual screening pipelines. The tools and frameworks he develops are contributing to faster, more cost-effective drug discovery, influencing pharmaceutical research worldwide.

🔮 Legacy and Future Contributions

Looking forward, Dr. Li is poised to play a pivotal role in integrating AI and machine learning with drug discovery, especially in the design of multi-targeted and personalized therapies. His ongoing efforts in de novo drug design and protein interface targeting are expected to lead to significant breakthroughs in therapeutic innovation. As a mentor and thought leader, he continues to inspire a new generation of researchers in medicinal chemistry and computational biology.

Publications

  • 📄 Examining the role of tap cell in suppressing single event transient effect in 28-nm CMOS technology
    Authors: Chenyu Zhang, Yan Li, Wenfa Zhan, Wenping Geng, Ting Liang, Xiaoyang Zeng
    Journal: Microelectronics Journal
    Year: 2024

  • 📄 A Non-Redundant Latch With Key-Node-Upset Obstacle of Beneficial Efficiency for Harsh Environments Applications
    Authors: Yan Liu, Yan Li, Xu Cheng, Jun Han, Xiaoyang Zeng
    Journal: IEEE Transactions on Circuits and Systems I: Regular Papers
    Year: 2023

  • 📄 DMBF: Design Metrics Balancing Framework for Soft-Error-Tolerant Digital Circuits Through Bayesian Optimization
    Authors: Yan Li, Chao Chen, Xu Cheng, Jun Han, Xiaoyang Zeng
    Journal: IEEE Transactions on Circuits and Systems I: Regular Papers
    Year: 2023

  • 📄 Impact of Tap Cell on Single Event Transient in 28-nm CMOS Technology
    Authors: Chenyu Zhang, Chiyu Tan, Yan Li, Xu Cheng, Jun Han, Xiaoyang Zeng
    Journal: European Conference on Radiation and Its Effects on Components and Systems, RADECS
    Year: 2022

  • 📄 Pulse Quenching Effect Characterized by Inverter Chains under Heavy-ion Irradiation in 28-nm CMOS Technology
    Authors: Chiyu Tan, Yan Li, Shaohang Chu, Rongmei Chen, Xu Cheng, Jun Han, Xiaoyang Zeng
    Journal: European Conference on Radiation and Its Effects on Components and Systems, RADECS
    Year: 2022

 

S. Azhagu Madhavan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. S. Azhagu Madhavan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Saveetha University | India

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. S. Azhagu Madhavan’s academic journey is rooted deeply in the life sciences, with a steadfast commitment to zoology and biotechnology. He completed his B.Sc., M.Sc., and Ph.D. at the prestigious A.V.V.M. Sri Pushpam College, affiliated with Bharathidasan University, Tamil Nadu, India. His academic curiosity led him from foundational studies in zoology and biotechnology to advanced research, culminating in a doctoral thesis titled “Elucidating the Pharmacological Effect of Costus Spicatus Rhizome Extract in Streptozotocin Induced Diabetic Albino Wistar Rats.” 🧪🧬 His early academic work also explored microbial biodiversity within earthworm guts, revealing his interest in both macro and micro life sciences.

🧑‍🔬 Professional Endeavors

With nearly five years of experience in academia and research, Dr. Madhavan has been shaping the minds of future scientists. He currently serves as an Assistant Professor at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai. Prior to this, he honed his research skills as a Research Associate at Global Scientific Research Services and as a Research Assistant at Harman Institute of Science Education and Research. His journey reflects a blend of academic rigor and practical experience, contributing meaningfully to the scientific community.

🔍 Contributions and Research Focus

Dr. Madhavan’s research encompasses a wide range of cutting-edge disciplines including pharmacology, phytochemistry, nanobiotechnology, pharmaceuticals, and agricultural entomology. His scholarly efforts have led to impactful discoveries, especially in the synthesis and application of bioactive compounds and nanomaterials. His work on silver nanoparticles, biomarkers in autoimmune and neurological disorders, and natural therapeutic agents stands out for its translational value in modern medicine. His diverse research interests continue to evolve with interdisciplinary collaborations.

🏆 Accolades and Recognition

Dr. Madhavan’s academic brilliance has not gone unnoticed. In 2020, he was honored with the International Young Scientist Award at the 7th International Scientist Awards on Engineering, Science, and Medicine by VDGOOD Professional Association. He has also been recognized at several national conferences for his innovative contributions and oral presentations, including awards for his early research on earthworm-associated microbiota. His invited talks and memberships in peer-reviewed scholarly publishing forums further validate his scientific excellence.

🌍 Impact and Influence

Dr. Madhavan has made a global impact through his research, with multiple Q1 journal publications in top-tier platforms like Elsevier, Springer, and the Royal Society of Chemistry. His work has contributed to our understanding of nanomedicine, immunology, forensic neuroscience, and plant-based bioactive therapies, gaining recognition from peers worldwide. His designs, patented under the Indian IPR system, including innovations like biosensors, UV chambers, and biodegradable delivery systems, are already making waves in health tech and agriculture.

🌟 Legacy and Future Contributions

Dr. Madhavan is poised to leave a lasting legacy in biomedical and biotechnological research. His future plans likely include expanding interdisciplinary research, mentoring young scientists, and driving innovation through sustainable and impactful science. His visionary approach—combining traditional knowledge with modern scientific tools like nanotechnology and pharmacogenomics—positions him as a transformative figure in life sciences. As a passionate educator and a dynamic researcher, his contributions will continue shaping science and society.

Publications

📄 Identification and characterization of silver nanoparticles from Erythrina indica and its antioxidant and Uropathogenic antimicrobial properties
Authors: Sivalingam, Azhagu Madhavan; Pandian, Arjun
Journal: Microbial Pathogenesis
Year: 2024

📄 Exosomes in Regulating miRNAs for Biomarkers of Neurodegenerative Disorders
Authors: Sivalingam, Azhagu Madhavan; Sureshkumar, Darshitha D.
Journal: Molecular Neurobiology
Year: 2025

📄 Fungal pretreatment methods for organic wastes: advances and challenges in biomass valorization
Authors: Chaurasia, P.K.; Bharati, S.L.; Singh, S.; Sivalingam, A.M.; Shankar, S.; Mani, A.
Journal: RSC Sustainability
Year: 2025

📄 Antihyperglycemic Activity of Polyphenolic Metabolites and Biosynthesized Silver Nanoparticles from Pedalium murex: Characterization and Application of Antioxidant and Uropathogenic Antimicrobial Activities
Authors: Azhagu Madhavan Sivalingam; Arjun Pandian
Journal: Microbial Pathogenesis
Year: 2025

📄 Cerebellar pathology in forensic and clinical neuroscience
Authors: Azhagu Madhavan Sivalingam; Darshitha D. Sureshkumar; Vijayalakshmi Pandurangan
Journal: Ageing Research Reviews
Year: 2025

Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Vishal Srivastava | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Cleveland Clinic | United States

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Vishal Srivastava’s journey in academia began with a strong foundation in his chosen field of study. His passion for scientific exploration was evident from an early stage, as he pursued rigorous academic training. Excelling in his undergraduate and postgraduate studies, he displayed an exceptional ability to understand complex scientific concepts. His pursuit of higher education led him to specialize in cutting-edge research areas, setting the stage for his remarkable contributions to academia and industry.

Professional Endeavors 💼

With a solid academic background, Dr. Vishal Srivastava embarked on a distinguished professional career, contributing his expertise to both academic institutions and research organizations. Over the years, he has taken on key roles that allowed him to bridge the gap between theoretical knowledge and practical applications. His leadership in various projects has been instrumental in shaping advancements within his domain, and his contributions continue to impact the scientific community.

Contributions and Research Focus 🔬

Dr. Vishal Srivastava has dedicated his research efforts to groundbreaking studies that have significantly advanced knowledge in his field. His work spans multiple innovative areas, focusing on addressing real-world challenges through scientific inquiry and technological solutions. With a keen interest in emerging trends, he has contributed to numerous publications and research collaborations, further solidifying his reputation as a thought leader. His research findings have not only added to academic literature but have also been applied in practical scenarios, demonstrating the real-world relevance of his work.

Accolades and Recognition 🏆

Dr. Vishal Srivastava’s contributions have been widely acknowledged, earning him prestigious accolades and recognitions from academic and professional organizations. His work has been featured in esteemed journals, and he has received awards for his pioneering research. These honors reflect his dedication, perseverance, and commitment to advancing knowledge in his field. His reputation as a scholar and innovator continues to grow as he receives invitations to share his insights at conferences, workshops, and industry events.

Impact and Influence 🌍

Beyond his research and professional achievements, Dr. Vishal Srivastava has played a crucial role in mentoring young researchers and students. His guidance has inspired many to explore new ideas and push the boundaries of conventional knowledge. His contributions extend beyond academia, as he actively collaborates with industry partners to bring research-driven innovations into real-world applications. Through his work, he has influenced policies, technological developments, and scientific progress, leaving a lasting impact on the field.

Legacy and Future Contributions 🚀

Dr. Vishal Srivastava’s legacy is one of innovation, excellence, and dedication to the pursuit of knowledge. As he continues his journey, he remains committed to pioneering research that addresses pressing global challenges. His future endeavors promise to bring further advancements, making significant contributions to science and technology. Through his ongoing work, he will continue to inspire future generations, shaping the future of research and innovation.

Publications

  •  📄Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion
    Journal: Biomolecules
    Year: 2025
    Authors: Vishal Srivastava, Zhigang Liu, Wei Wei, Yuan Zhang, James C. Paton, Adrienne W. Paton, Tingwei Mu, Bin Zhang

  •  📄 Mammalian Cargo Receptors for Endoplasmic Reticulum-to-Golgi Transport: Mechanisms and Interactions
    Journal: Biochemical Society Transactions
    Year: 2023
    Authors: Zhang Y, Srivastava V, Zhang B

  •  📄 The Combined Escherichia coli Nissle 1917 and Tryptophan Treatment Modulates Immune and Metabolome Responses to Human Rotavirus Infection in a Human Infant Fecal Microbiota Transplanted Malnourished Gnotobiotic Pig Model
    Journal: mSphere
    Year: 2022
    Authors: Michael H, Srivastava V, Deblais L, Amimo JO, Chepngeno J, Saif LJ, Rajashekara G, Vlasova AN

  •  📄 Obese Children Gut Microbiota Influences Inflammatory Mucosal Immune Pathways in the Respiratory Tract to Influenza Virus Infection: Optimization of an Ideal Duration of Microbial Colonization in a Gnotobiotic Pig Model
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Renu S, Deblais L, Patil V, Schrock J, Kathayat D, Srivastava V, Feliciano-Ruiz N, Han Y, Ramesh A, Lakshmanappa Y S, Ghimire S, Dhakal S, Rajashekara G, Renukaradhya G J

  •  📄 Evaluation of Novel Quorum Sensing Inhibitors Targeting Autoinducer 2 (AI-2) for the Control of Avian Pathogenic Escherichia coli Infections in Chickens
    Journal: Microbiology Spectrum
    Year: 2022
    Authors: Helmy Y A, Kathayat D, Deblais L, Srivastava V, Closs G, Tokarski IIR J, Ayinde O, Fuchs J R, Rajashekara G

 

Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

Published on by Book of Award

Dr. Inmaculada Gilaberte | Medicine and Dentistry | Best Researcher Award

FAES Farma | Spain

Author Profile

Scopus

🌱 Early Academic Pursuits

Dr. Inmaculada Gilaberte’s academic journey is rooted in a commitment to excellence and medical advancement. She initially pursued education in clinical research, equipping herself with in-depth knowledge and skills in therapeutic areas such as neuroscience and immunology. Her academic foundation was further strengthened by certifications, including a lecturer certification from the Spanish Quality Register Agency (ANECA), and advanced leadership programs from institutions like Stanford and MIT. These formative experiences shaped her growth mindset, laying the groundwork for a career dedicated to precision, patient-centered care, and effective team collaboration.

💼 Professional Endeavors

Throughout her career, Dr. Gilaberte has held prominent roles in major pharmaceutical companies such as FAES FARMA, Takeda, TiGenix, Roche, and Lilly, with positions spanning from Clinical Research Physician to Director of Clinical Research. She has led various departments, managed global teams, and directed clinical trials across multiple therapeutic areas, including gastroenterology, immunology, cardiology, and pain management. Her strategic guidance has driven several landmark projects forward, including the advancement of microbiome and cell therapies from preclinical to first-in-human trials, demonstrating her expertise in transforming innovative therapies into viable treatment options.

🧬 Contributions and Research Focus

Dr. Gilaberte has made notable contributions to clinical research, particularly in stem cell therapy, immunology, and neuroscience. Her pioneering work on Darvadstrocel, an allogeneic adipose-derived mesenchymal stem cell therapy, led to significant strides in treating perianal fistulas and positioned her as a leader in regenerative medicine. She has been instrumental in launching global clinical trials, developing target product profiles (TPP), and submitting regulatory applications for FDA and EMA approvals. With a robust publication record, including 66 papers indexed in PubMed, she continues to contribute to scientific literature, sharing her findings and advancing the field of biomedicine.

🏆 Accolades and Recognition

Dr. Gilaberte’s excellence has been recognized through numerous awards across her roles in clinical development and leadership. Her achievements include multiple awards for her work in the clinical progression of innovative therapies and successful drug submissions to global regulatory bodies. She has received recognition for her strategic contributions to the Darvadstrocel trials and for advancing neuroscience programs in Alzheimer’s disease. Her leadership has earned her high regard in the industry, with acknowledgments from institutions and colleagues alike.

🌍 Impact and Influence

Dr. Gilaberte’s impact extends beyond her immediate professional roles. Her contributions to clinical science have enhanced treatment options for patients with complex diseases, and her leadership has shaped clinical strategies in multinational pharmaceutical companies. She has also promoted effective collaboration across global, cross-functional teams, fostering a diverse and inclusive work environment that prioritizes patient needs. Her initiatives in regulatory compliance, risk management, and data integration have set new standards for clinical operations, solidifying her influence as a thought leader in her field.

📜 Legacy and Future Contributions

Looking ahead, Dr. Gilaberte’s legacy is one of commitment to advancing patient care through innovation, collaboration, and strategic foresight. Her future endeavors are poised to make an enduring impact, with ongoing research and leadership contributions that will shape the future of clinical development. Her philanthropic work, such as building a nursery in Uganda, highlights her dedication to global well-being beyond her professional achievements. Dr. Gilaberte continues to inspire the next generation of clinical researchers, ensuring that her legacy of precision, empathy, and patient-first innovation will endure.

 

Publications

📄 Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial

  • Authors: Esteban Jódar-Gimeno, Jose Luis Pérez-Castrillón, Ján Nociar, Michal Lojka, Dimitar Nikolov, Fernando Cereto-Castro, Snežana Novković, Umberto Tarantino, Nadia Mehsen-Cetre, Paula Arranz, Cristina Martínez Ostalé, Aintzane García-Bea, Inmaculada Gilaberte
  • Journal: Nutrients
  • Year: 2024

📄 Comparative inhibition by oral bilastine, parenteral dexchlorpheniramine, and a new bilastine parenteral (i.v. and i.m.) formulation of histamine-induced wheal and flare response: A randomised phase I trial

  • Authors: Coimbra, J., Puntes, M., Molina, P., Arranz, P., Sánchez, C.
  • Journal: European Journal of Pharmaceutical Sciences
  • Year: 2024

📄  Bioequivalence and Safety of Bilastine 20 mg Orodispersible Tablets and Conventional Tablets: A Randomized, Single-Dose, Two-Period Crossover Study in Healthy Volunteers Under Fasting Conditions

  • Authors: Román, M., Ochoa, D., Martin, S., Arranz, P., Sánchez, C.
  • Journal: Drugs in R and D
  • Year: 2024

📄  Disease Burden, Treatment Patterns, and Economic Impact of Rectovaginal Fistulas in Patients with Crohn’s Disease: Findings from a Retrospective, Observational, Longitudinal Study Based on US Claims Databases

  • Authors: Karki, C., Latremouille-Viau, D., Gilaberte, I., Romdhani, H., Lightner, A.L.
  • Journal: PharmacoEconomics
  • Year: 2023

📄  Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients With Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial

  • Authors: Garcia-Olmo, D., Gilaberte, I., Binek, M., Spinelli, A., Panés, J.
  • Journal: Diseases of the Colon and Rectum
  • Year: 2022

 

Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by Book of Award

Dr. Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China                    

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors 🏅

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus 🔬

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

  • His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
  • He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
  • Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition 🏆

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

  • National Encouragement Scholarship
  • Zhixing Scholarship for Postgraduate Students
  • Doctoral Research Incentive Scholarship
  • Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence 🌍

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions 🚀

Dr. Saxu’s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

 

Publications

📜 Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

  • Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

📜 Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

  • Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

 

Govindaraj Sabarees | Materials Science | Best Researcher Award

Published on by Book of Award

Dr. Govindaraj Sabarees | Materials Science | Best Researcher Award

Shri Venkateshwara College of Pharmacy | India

Author Profile

Orcid

Google Scholar

Early Academic Pursuits 🎓

Dr. Govindaraj Sabarees began his academic journey with a solid foundation in pharmacy. He earned his B. Pharmacy degree from Sankaralingam Bhuvaneshwari College of Pharmacy, Sivakasi, Tamil Nadu, achieving first-class honors. This was followed by an M. Pharmacy in Pharmaceutical Chemistry from C.L. Baid Metha College of Pharmacy, Chennai, where he also graduated with first-class distinction. His academic achievements laid the groundwork for his research-oriented career.

Professional Endeavors 🏢

Dr. Sabarees gained significant experience as a Bioanalytical Research Associate at Amaris Clinical, a division of Caplin Point Laboratories, Chennai. During this period, he honed his skills in bioanalytical methods, high-end equipment handling, and synthetic organic chemistry. His hands-on experience in these areas has contributed to his expertise in pharmaceutical research, particularly in the development and validation of analytical methods.

Contributions and Research Focus 🔬

Dr. Sabarees has made substantial contributions to pharmaceutical research, particularly in the field of wound healing and molecular docking. His research includes the discovery of curcumin analogs as potential wound healing agents and the development of novel electrospun nanofibers for biomedical applications. His work has been widely published in reputable journals, showcasing his ability to bridge the gap between theoretical research and practical applications in medicine.

Accolades and Recognition 🏆

Throughout his career, Dr. Sabarees has received recognition for his contributions to pharmaceutical research. His participation in various national and international conferences, where he has presented his findings, has earned him a respected place in the academic and research community. His publications in high-impact journals further underscore his commitment to advancing the field of pharmaceutical sciences.

Impact and Influence 🌍

Dr. Sabarees's research has had a significant impact on the development of new therapeutic agents and materials, particularly in the area of wound management. His work on molecular docking and dynamics simulations has opened new avenues for drug discovery and development. His influence extends to his role as a mentor and educator, where he has guided junior researchers and pharmacy students, helping shape the next generation of pharmaceutical scientists.

Legacy and Future Contributions 🌟

As Dr. Sabarees continues to advance in his career, his ongoing research and future projects promise to make lasting contributions to the field of pharmaceutical sciences. His work on electrospun nanofibers and molecular docking is likely to lead to new breakthroughs in drug delivery systems and therapeutic materials. Dr. Sabarees's legacy will be one of innovation, dedication, and a commitment to improving healthcare outcomes through cutting-edge research.

 

Publications

  • 📖 Fabrication of Quercetin-Functionalized Morpholine and Pyridine Motifs-Laden Silk Fibroin Nanofibers for Effective Wound Healing in Preclinical Study
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Siddan Gouthaman, Viswas Raja Solomon, Subramani Kandhasamy
    Journal: Pharmaceutics
    Year: 2024
  • 📖 Advances in Electrospun Chitosan Nanofiber Biomaterials for Biomedical Applications
    Authors: Ganesan Padmini Tamilarasi, Manikandan Krishnan, Govindaraj Sabarees, S. Gouthaman, Alagarsamy Veerchamy, Viswas Raja Solomon
    Journal: Materials Advances
    Year: 2023
  • 📖 Discovery of new naphthyridine hybrids against enoyl-ACP reductase (inhA) protein target of Mycobacterium tuberculosis: Molecular docking, molecular dynamics simulations studies
    Authors: Govindaraj Sabarees, Vadivel Velmurugan, Viswas Raja Solomon
    Journal: Chemical Physics Impact
    Year: 2023
  • 📖 Recent Trends in Electrospun Antibacterial Nanofibers for Chronic Wound Management
    Authors: Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Krishnan Manikandan, Siddan Gouthaman, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Current Nanomedicine
    Year: 2023
  • 📖Recent Developments in Electrospun Nanofibers as Delivery of Phytoconstituents for Wound Healing
    Authors: Govindaraj Ajith, Ganesan Padmini Tamilarasi, Govindaraj Sabarees, Siddan Gouthaman, Krishnan Manikandan, Vadivel Velmurugan, Veerachamy Alagarsamy, Viswas Raja Solomon
    Journal: Drugs and Drug Candidates
    Year: 2023

 

Thiruchelvi R | Engineering | Young Scientist Award

Published on by Book of Award

Mrs. Thiruchelvi R | Engineering | Young Scientist Award

St.Jospehs College of Engineering | India

Author profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Mrs. Thiruchelvi R's academic journey began at John Bosco Matriculation Higher Secondary School in Kovilpatti, where she completed her SSLC in May 2004 with an impressive 85% score. She continued her education at St. Pauls Matriculation Higher Secondary School, where she pursued Mathematics and Biology, achieving 82% in her HSC in May 2006. Her passion for biotechnology led her to pursue a B.Tech in Biotechnology at P.S.R. Engineering College, Sivakasi, under Anna University, Chennai, graduating in May 2010 with a remarkable 86% CGPA. She further honed her expertise with an M.Tech in Biotechnology from Kamaraj College of Engineering and Technology, Virudhunagar, where she excelled with a 9.2 CGPA in May 2012. Currently, she is pursuing her Ph.D. in Biotechnology at St. Joseph College of Engineering and Technology, Chennai, under Anna University, set to complete in November 2025.

💼 Professional Endeavors

Mrs. Thiruchelvi embarked on her professional journey as an Assistant Professor at Vels Institute of Science Technology and Advanced Studies (VISTAS), serving from July 2017 to April 2023. Her role as a Senior Research Technical Consultant at Aman Aqua Bio Chemical, focusing on chemical-free plant activators, further solidified her position as a leading researcher. Since May 2023, she has been contributing her expertise in India and Abu Dhabi.

🧬 Contributions and Research Focus

Mrs. Thiruchelvi's research interests are deeply rooted in Marine Biotechnology, Nanobiotechnology, and the valorization of fruit waste for value-added products. Her technical skills encompass a wide array of expertise, from the extraction and characterization of biological compounds from macroalgae and fruit waste to enzyme kinetics and drug design. Her work in optimizing methodologies and supervising interdisciplinary research projects has been instrumental in advancing biotechnology applications.

🏆 Accolades and Recognition

Mrs. Thiruchelvi's contributions have been recognized with numerous awards, including the prestigious Young Women Tech Innovator Award in April 2023 and the Academic Achiever Award in March 2023. Her achievements also include the Best Woman Scientist Award in September 2022 and the Best Woman Award for Excellence and Innovation in April 2022. Her accolades reflect her dedication and innovation in the field of biotechnology.

🌍 Impact and Influence

Through her extensive research and development work, Mrs. Thiruchelvi has made significant strides in providing sustainable solutions for the bioenergy industry. Her expertise in macroalgae cultivation, enzyme kinetics, and drug design has not only contributed to academic knowledge but also to practical applications that benefit society. Her role in mentoring students and guiding research projects has left a lasting impact on the next generation of scientists.

🏅 Legacy and Future Contributions

As Mrs. Thiruchelvi continues her research and academic endeavors, her legacy is set to grow. Her contributions to biotechnology, particularly in sustainable biomass supply and marine biotechnology, are paving the way for future innovations. Her dedication to teaching, research, and industry collaboration ensures that her influence will extend far beyond her immediate work, inspiring future researchers and contributing to the global scientific community.

 

Publications 📚

  • 📜In Silico Studies of the Hepatitis B Viral Protein for Drug Discovery
    Authors: Arun, S.P. , Thiruchelvi, R. , Rajakumari, K.
    Journal: Oxidation Communications
    Year: 2023
  • 📜Nanotheranostics for Cancer Therapy and Detection: Strategies, Promises, and Impediments
    Authors: Jacqulyn, V. , Priya, S.L. , Thiruchelvi, R. , Rajakumari, K.
    Journal: Oxidation Communications
    Year: 2023
  • 📜Chitosan Nanoparticle Encapsulated with Terminalia chebula – In Vitro Antidiabetic Activity
    Authors: Nath, R. , Rajakumari, K. , Thiruchelvi, R. , Ivo Romauld, S. , Vivek, P.
    Journal: Oxidation Communications
    Year: 2023
  • 📜Collagen – Zinc Oxide Nanoparticles (ZnO NPs) Composites for Wound Healing – A Review
    Authors: Thiruchelvi, R. , Priyadharshini, S. , Mugunthan, P. , Rajakumari, K.
    Journal: Research Journal of Pharmacy and Technology
    Year: 2022
  • 📜The Phytochemical Components of Caesalpinia Sappan in Treating Respiratory Ailments Through an Herbal Soup in Addition with Sensory Evaluation
    Authors: Moyeenudin, H.M. , Thiruchelvi, R. , Wilfred Lawrence, A. , John Williams, R.
    Journal: Materials Today: Proceedings
    Year: 2022